Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?

Cole Maguire, Teresa Frohman, Scott S. Zamvil, Elliot Frohman, Esther Melamed

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalNeurology(R) neuroimmunology & neuroinflammation
Issue number5
StatePublished - Sep 1 2020

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this